Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Buy
53
HRTS Quote, Financials, Valuation and Earnings
Last price:
$35.25
Seasonality move
:
10.1%
Day range:
$35.28 - $35.65
52-week range:
$25.32 - $36.20
Dividend yield:
0.4%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
5.4K
Avg. volume:
8.4K
1-year change:
10.38%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- |
|
TMED
Trimedyne
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
HRTS
Tema Heart & Health ETF
|
$35.35 | -- | -- | -- | $0.47 | 0.4% | -- |
|
AGNG
Global X Aging Population ETF
|
$36.31 | -- | -- | -- | $0.14 | 0.79% | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
$46.88 | -- | -- | -- | $0.03 | 0.07% | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$58.01 | -- | -- | -- | $0.33 | 4.86% | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
$33.50 | -- | -- | -- | $0.51 | 1.37% | -- |
|
TMED
Trimedyne
|
-- | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
HRTS
Tema Heart & Health ETF
|
-- | 0.753 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.484 | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | 1.886 | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.523 | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | 0.449 | -- | -- |
|
TMED
Trimedyne
|
-- | 0.000 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDX
Horizon Kinetics Medical ETF
|
-- | -- | -- | -- | -- | -- |
|
TMED
Trimedyne
|
-- | -- | -- | -- | -- | -- |
Tema Heart & Health ETF vs. Competitors
-
Which has Higher Returns HRTS or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Tema Heart & Health ETF's net margin of --. Tema Heart & Health ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema Heart & Health ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About HRTS or AGNG?
Tema Heart & Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Heart & Health ETF has higher upside potential than Global X Aging Population ETF, analysts believe Tema Heart & Health ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema Heart & Health ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is HRTS or AGNG More Risky?
Tema Heart & Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.743, suggesting its less volatile than the S&P 500 by 25.722%.
-
Which is a Better Dividend Stock HRTS or AGNG?
Tema Heart & Health ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 0.4%. Global X Aging Population ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $0.14 per share. Tema Heart & Health ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or AGNG?
Tema Heart & Health ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Tema Heart & Health ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Tema Heart & Health ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Heart & Health ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema Heart & Health ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns HRTS or GNOM?
Global X Genomics & Biotechnology ETF has a net margin of -- compared to Tema Heart & Health ETF's net margin of --. Tema Heart & Health ETF's return on equity of -- beat Global X Genomics & Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema Heart & Health ETF-- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -
What do Analysts Say About HRTS or GNOM?
Tema Heart & Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Genomics & Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Heart & Health ETF has higher upside potential than Global X Genomics & Biotechnology ETF, analysts believe Tema Heart & Health ETF is more attractive than Global X Genomics & Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema Heart & Health ETF0 0 0 GNOMGlobal X Genomics & Biotechnology ETF0 0 0 -
Is HRTS or GNOM More Risky?
Tema Heart & Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Genomics & Biotechnology ETF has a beta of 1.286, suggesting its more volatile than the S&P 500 by 28.563%.
-
Which is a Better Dividend Stock HRTS or GNOM?
Tema Heart & Health ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 0.4%. Global X Genomics & Biotechnology ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.03 per share. Tema Heart & Health ETF pays -- of its earnings as a dividend. Global X Genomics & Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or GNOM?
Tema Heart & Health ETF quarterly revenues are --, which are smaller than Global X Genomics & Biotechnology ETF quarterly revenues of --. Tema Heart & Health ETF's net income of -- is lower than Global X Genomics & Biotechnology ETF's net income of --. Notably, Tema Heart & Health ETF's price-to-earnings ratio is -- while Global X Genomics & Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Heart & Health ETF is -- versus -- for Global X Genomics & Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema Heart & Health ETF-- -- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- --
-
Which has Higher Returns HRTS or JDOC?
JPMorgan Healthcare Leaders ETF has a net margin of -- compared to Tema Heart & Health ETF's net margin of --. Tema Heart & Health ETF's return on equity of -- beat JPMorgan Healthcare Leaders ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema Heart & Health ETF-- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- -
What do Analysts Say About HRTS or JDOC?
Tema Heart & Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand JPMorgan Healthcare Leaders ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Heart & Health ETF has higher upside potential than JPMorgan Healthcare Leaders ETF, analysts believe Tema Heart & Health ETF is more attractive than JPMorgan Healthcare Leaders ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema Heart & Health ETF0 0 0 JDOCJPMorgan Healthcare Leaders ETF0 0 0 -
Is HRTS or JDOC More Risky?
Tema Heart & Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison JPMorgan Healthcare Leaders ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HRTS or JDOC?
Tema Heart & Health ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 0.4%. JPMorgan Healthcare Leaders ETF offers a yield of 4.86% to investors and pays a quarterly dividend of $0.33 per share. Tema Heart & Health ETF pays -- of its earnings as a dividend. JPMorgan Healthcare Leaders ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or JDOC?
Tema Heart & Health ETF quarterly revenues are --, which are smaller than JPMorgan Healthcare Leaders ETF quarterly revenues of --. Tema Heart & Health ETF's net income of -- is lower than JPMorgan Healthcare Leaders ETF's net income of --. Notably, Tema Heart & Health ETF's price-to-earnings ratio is -- while JPMorgan Healthcare Leaders ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Heart & Health ETF is -- versus -- for JPMorgan Healthcare Leaders ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema Heart & Health ETF-- -- -- -- JDOCJPMorgan Healthcare Leaders ETF-- -- -- --
-
Which has Higher Returns HRTS or MEDX?
Horizon Kinetics Medical ETF has a net margin of -- compared to Tema Heart & Health ETF's net margin of --. Tema Heart & Health ETF's return on equity of -- beat Horizon Kinetics Medical ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema Heart & Health ETF-- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- -
What do Analysts Say About HRTS or MEDX?
Tema Heart & Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Horizon Kinetics Medical ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Heart & Health ETF has higher upside potential than Horizon Kinetics Medical ETF, analysts believe Tema Heart & Health ETF is more attractive than Horizon Kinetics Medical ETF.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema Heart & Health ETF0 0 0 MEDXHorizon Kinetics Medical ETF0 0 0 -
Is HRTS or MEDX More Risky?
Tema Heart & Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Horizon Kinetics Medical ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HRTS or MEDX?
Tema Heart & Health ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 0.4%. Horizon Kinetics Medical ETF offers a yield of 1.37% to investors and pays a quarterly dividend of $0.51 per share. Tema Heart & Health ETF pays -- of its earnings as a dividend. Horizon Kinetics Medical ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or MEDX?
Tema Heart & Health ETF quarterly revenues are --, which are smaller than Horizon Kinetics Medical ETF quarterly revenues of --. Tema Heart & Health ETF's net income of -- is lower than Horizon Kinetics Medical ETF's net income of --. Notably, Tema Heart & Health ETF's price-to-earnings ratio is -- while Horizon Kinetics Medical ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Heart & Health ETF is -- versus -- for Horizon Kinetics Medical ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema Heart & Health ETF-- -- -- -- MEDXHorizon Kinetics Medical ETF-- -- -- --
-
Which has Higher Returns HRTS or TMED?
Trimedyne has a net margin of -- compared to Tema Heart & Health ETF's net margin of --. Tema Heart & Health ETF's return on equity of -- beat Trimedyne's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital HRTSTema Heart & Health ETF-- -- -- TMEDTrimedyne-- -- -- -
What do Analysts Say About HRTS or TMED?
Tema Heart & Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Trimedyne has an analysts' consensus of -- which suggests that it could fall by --. Given that Tema Heart & Health ETF has higher upside potential than Trimedyne, analysts believe Tema Heart & Health ETF is more attractive than Trimedyne.
Company Buy Ratings Hold Ratings Sell Ratings HRTSTema Heart & Health ETF0 0 0 TMEDTrimedyne0 0 0 -
Is HRTS or TMED More Risky?
Tema Heart & Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Trimedyne has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock HRTS or TMED?
Tema Heart & Health ETF has a quarterly dividend of $0.47 per share corresponding to a yield of 0.4%. Trimedyne offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Tema Heart & Health ETF pays -- of its earnings as a dividend. Trimedyne pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios HRTS or TMED?
Tema Heart & Health ETF quarterly revenues are --, which are smaller than Trimedyne quarterly revenues of --. Tema Heart & Health ETF's net income of -- is lower than Trimedyne's net income of --. Notably, Tema Heart & Health ETF's price-to-earnings ratio is -- while Trimedyne's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Tema Heart & Health ETF is -- versus -- for Trimedyne. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income HRTSTema Heart & Health ETF-- -- -- -- TMEDTrimedyne-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 62.68% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 8.8% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 5.82% over the past day.
